Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol Versus Triamcinolone in Hypertrophic Lichen Planus
NCT07666620Phase 4Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in Hypertrophic Lichen Planus (HLP) comparing Topical Clobetasol Propionate with Intralesional Triamcinolone Acetonide (2 arms). Primary endpoint: Lichen Planus Severity Index at 12 weeks. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
clobetasoltriamcinolone acetonide
03
Conditions
Hypertrophic Lichen Planus (HLP)
Beyond the preview
Go deeper on NCT07666620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07666620.